Skip to main content
. Author manuscript; available in PMC: 2016 Sep 12.
Published in final edited form as: Clin Gastroenterol Hepatol. 2014 Oct 24;13(3):552–e29. doi: 10.1016/j.cgh.2014.10.015

Table 4.

Individual imaging findings by temporal nature and severity of pain in chronic pancreatitis patients in the NAPS2-CV study

Variable All
Patients
(518)
Temporal Severity
No pain
(81)
Intermittent
(165)
Constant
(272)
p-
value
No pain
(81)
Mild
(91)
Severe
(346)
p-
value
Calcification 276 (53.3) 49 (60.5) 95 (57.6) 132 (48.5) 0.07 49 (60.5) 49 (53.9) 178 (51.5) 0.34
Calcification* 286 (55.2) 51 (63) 100 (60.6) 135 (49.6) 0.0256 51 (63) 53 (58.2) 182 (52.6) 0.20
Atrophy 281 (54.3) 50 (61.7) 85 (51.5) 146 (53.7) 0.31 50 (61.7) 53 (58.2) 178 (51.5) 0.17
Atrophy* 297 (57.3) 53 (65.4) 88 (53.3) 156 (57.4) 0.20 53 (65.4) 56 (61.5) 188 (54.3) 0.13
PD Dilatation 317 (61.2) 50 (61.7) 108 (65.5) 159 (58.5) 0.34 50 (61.7) 58 (63.7) 209 (60.4) 0.84
PD Dilatation* 350 (67.6) 52 (64.2) 119 (72.1) 179 (65.8) 0.31 52 (64.2) 64 (70.3) 234 (67.6) 0.69
PD Stricture/Obstruction 103 (19.9) 10 (12.4) 42 (25.5) 51 (18.8) 0.0424 10 (12.4) 18 (19.8) 75 (21.7) 0.17
PD Stricture/Obstruction* 142 (27.4) 17 (21) 52 (31.5) 73 (26.8) 0.21 17 (21) 25 (27.5) 100 (28.9) 0.36
Pseudocyst 137 (26.5) 16 (19.8) 42 (25.5) 79 (29) 0.24 16 (19.8) 29 (31.9) 92 (26.6) 0.20
Pseudocyst* 167 (32.2) 19 (23.5) 52 (31.5) 96 (35.3) 0.13 19 (23.5) 33 (36.3) 115 (33.2) 0.16
PD Irregularity 266 (51.4) 34 (42) 95 (57.6) 137 (50.4) 0.06 34 (42) 52 (57.1) 180 (52) 0.13
Inflammation 176 (34) 23 (28.4) 56 (33.9) 97 (35.7) 0.48 23 (28.4) 23 (25.3) 130 (37.6) 0.0453
Pancreatic Mass 30 (5.8) 6 (7.4) 12 (7.3) 12 (4.4) 0.37 6 (7.4) 4 (4.4) 20 (5.8) 0.70
Abnormal Side Branches 213 (41.1) 27 (33.3) 71 (43) 115 (42.3) 0.30 27 (33.3) 46 (50.6) 140 (40.5) 0.0661
CBD Stricture 61 (11.8) 9 (11.1) 29 (17.6) 23 (8.5) 0.02 9 (11.1) 13 (14.3) 39 (11.3) 0.72
CBD Dilatation 92 (17.8) 16 (19.8) 37 (22.4) 39 (14.3) 0.09 16 (19.8) 21 (23.1) 55 (15.9) 0.25
Changes suggestive of Cirrhosis and/or Portal Hypertension 64 (12.4) 7 (8.6) 20 (12.1) 37 (13.6) 0.49 7 (8.6) 11 (12.1) 46 (13.3) 0.52

Findings are those reported on the most recent imaging studies, except for those marked with an (*) which reflects findings reported on imaging studies performed anytime